Title:
ANTIBODY BINDING TO HUMAN NGF, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/218574
Kind Code:
A1
Abstract:
The present invention provides an antibody binding to human NGF or an antigen-binding fragment thereof, capable of effectively binding to human NGF and blocking a signaling pathway of NGF-TrKA, used for preparing drugs for treating NGF overexpressed diseases (such as trauma, inflammation, and chronic pain), and having good clinical application prospects.
More Like This:
| WO/2006/086469 | ANTIBODIES TO TGFBETA |
| JP5553603 | New cancer-of-liver marker |
| WO/2010/032060 | ANTIBODIES DIRECTED TO DLL4 AND USES THEREOF |
Inventors:
ZHU ZHENPING (CN)
HUANG HAOMIN (CN)
CHEN JIANHE (CN)
GUO WEI (CN)
ZHAO JIE (CN)
HUANG HAOMIN (CN)
CHEN JIANHE (CN)
GUO WEI (CN)
ZHAO JIE (CN)
Application Number:
PCT/CN2021/085534
Publication Date:
November 04, 2021
Filing Date:
April 06, 2021
Export Citation:
Assignee:
SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD (CN)
International Classes:
C07K16/22; A61K39/395; A61P29/00; C12N15/13
Foreign References:
| CN109929035A | 2019-06-25 |
Attorney, Agent or Firm:
LECOME INTELLECTUAL PROPERTY AGENT LTD. (CN)
Download PDF:
Previous Patent: VIDEO PLAYING METHOD, APPARATUS AND SYSTEM, AND COMPUTER STORAGE MEDIUM
Next Patent: LAWN ARTIFICIAL-FILAMENT PLANTING MACHINE
Next Patent: LAWN ARTIFICIAL-FILAMENT PLANTING MACHINE